期刊文献+

新型冠状病毒肺炎危重型患者临床特征变化及心肺病理改变 被引量:7

Clinical feature changes of a COVID-19 patient from mild to critical condition and cardiopulmonary pathological results
原文传递
导出
摘要 目的分析新型冠状病毒肺炎(COVID-19)危重型患者的临床资料和心肺病理特征,为类似病例的临床救治提供借鉴。方法回顾性分析1例COVID-19患者从发病到危重型快速进展过程中的临床指标、实验室检查、支气管镜及超声心动图结果的动态变化和心肺病理解剖结果。结果该例患者在2019新型冠状病毒(2019-nCoV)感染后第9天入院。患者起病后从轻症到重症,再到危重症分别经历了12和18 d,在第28至45天期间接受了体外膜肺氧合(ECMO)联合连续性肾脏替代疗法(CRRT)以及心肺联合移植术,术后第2天死亡。患者有8年高血压病史。早期症状轻,炎症指标升高、淋巴细胞减少。治疗效果差,病情进展迅速,多次病毒核酸检测转阴之后病情仍加重,并逐渐发展为肺出血和实变,大量分泌物和肺内出血导致肺功能丧失、肺动脉高压、右心衰竭、恶性心律失常及肝功能异常。予右肺移植和原位心脏移植术后不能维持循环稳定而死亡。肺病理检查可见气管及支气管内存在大量黏液、暗红色分泌物和血块,病理改变主要为肺组织出血坏死、肺泡炎、纤维素性渗出和小血管病变,心肌细胞水肿和少量炎症细胞浸润。结论COVID-19危重型患者从轻症到危重症、死亡进展快速,危重症阶段发生肺、心和肝脏损伤。 ObjectiveTo analyse the clinical history,laboratory tests and pathological data of a patient who suffered from novel coronavirus pneumonia(COVID-19)and provide reference for the clinical treatment of similar cases.MethodsData of clinical manifestation,laboratory examination,bronchoscopy,echocardiography and cardiopulmonary pathological results were retrospectively reviewed in a case of COVID-19 with rapid exacerbation from mild to critical condition.ResultsThis patient hospitalized at day 9 post 2019 novel coronavirus(2019-nCoV)infection,experienced progressive deterioration from mild to severe at day 12,severe to critical at day 18 and underwent extracorporeal membrane oxygenation(ECMO)and continuous renal replacement therapy(CRRT)as well as heart lung transplantation during day 28-45 post infection,and died at the second day post heart and lung transplantation.The patient had suffered from hypertension for 8 years.At the early stage of the disease,his symptoms were mild and the inflammatory indices increased and the lymphocyte count decreased continuously.The patient′s condition exacerbated rapidly with multi-organ infections,and eventually developed pulmonary hemorrhage and consolidation,pulmonary hypertension,right heart failure,malignant ventricular arrhythmias,liver dysfunction,etc.His clinical manifestations could not be improved despite viral RNAs test results became negative.The patient underwent lung and heart transplantation and finally died of multi organ failure at the second day post lung and heart transplantation.Pathological examination indicated massive mucus,dark red secretions and blood clots in bronchus.The pathological changes were mainly diffused pulmonary hemorrhagic injuries and necrosis,fibrosis,small vessel disease with cardiac edema and lymphocyte infiltration.ConclusionsThe clinical course of severe COVID-19 can exacerbate rapidly from mild to critical with lung,liver and heart injuries.
作者 江思维 高虹 吴林 王国伟 岑福兰 李金秀 冯程 温隽岷 陈烨 何仁亮 乔坤 汪英 刘映霞 王召钦 Jiang Siwei;Gao Hong;Wu Lin;Wang Guowei;Cen Fulan;Li Jinxiu;Feng Cheng;Wen Junmin;Chen Ye;He Renliang;Qiao Kun;Wang Ying;Liu Yingxia;Wang Zhaoqin(Department of Cardiology,Shenzhen Third People′s Hospitle,Shenzhen 518112,China;Department of Cardiology,Peking University First Hospital,Beijing 100034,China;Intensive Care Unit,Shenzhen Third People′s Hospitle,Shenzhen 518112,China;Department of Medical Ultrasonics,Shenzhen Third People′s Hospitle,Shenzhen 518112,China;Intensive Care Unit,Fuwai Hospital,Chinese Academy of Medical Sciences Shenzhen,Shenzhen 518057,China;Department of Hemodialysis,Shenzhen Third People′s Hospitle,Shenzhen 518112,China;Department of Anesthesia,Shenzhen Third People′s Hospitle,Shenzhen 518112,China;Department of Cardiothoracic Surgery,Shenzhen Third People′s Hospitle,Shenzhen 518112,China;Administration Office,Shenzhen Third People′s Hospitle,Shenzhen 518112,China)
出处 《中华心血管病杂志》 CAS CSCD 北大核心 2020年第7期580-580,581-586,共7页 Chinese Journal of Cardiology
关键词 新型冠状病毒肺炎 心脏损伤 心肺移植 体外膜肺氧合 COVID-19 Heart injuries Heart-lung transplantation Extracorporeal membrane oxygenation
  • 相关文献

参考文献5

二级参考文献40

  • 1谢钢,宁晔,蒋崇慧,李斌飞,张志刚,姜海明,吴美英,郑伟华,尹刚,赵双彪.体外膜肺氧合在严重肺挫伤中的应用研究[J].中华急诊医学杂志,2005,14(2):136-139. 被引量:6
  • 2荆志成.六分钟步行距离试验的临床应用[J].中华心血管病杂志,2006,34(4):381-384. 被引量:98
  • 3The Acute Respiratory Distress Syndrome Network. Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome[ J]. N Engl J Med ,2000 ,342 ( 18 ) : 1301-1308.
  • 4Erickson SE, Martin GS, Davis JL, et al. Recent trends in acute lung injury mortality: 1996-2005 [ J]. Crit Care Med, 2009,37 (5) :1574-1579.
  • 5Pesenti A, Zanella A, Patroniti N. Extracorporeal gas exchange [J]. Curr Opin Crit Care,2009,15( 1 ) :52-58.
  • 6Bernard GR, Artigas A, Brigham KL, et al. The American-European Consensus Conference on ARDS. Definitions, mechanisms, relevant outcomes, and clinical trial coordination[J]. Am J Respir Crit Care Med, 1994,149 (3/1) :818-824.
  • 7Jadad AR, Moore RA, Carroll D, et al. Assessing the quality of reports of randomized clinical trials : is blinding necessary [ J ]. Control Clin Trials,1996,17( 1 ) :1-12.
  • 8Zapol WM, Snider MT, Hill JD, et al. Extracorporeal membrane oxygenation in severe acute respiratory failure: a randomized prospective study [ J ]. JAMA, 1979,242 (20) :2193-2196.
  • 9Morris AH, Wallace CJ, Menlove RL, et al. Randomized clinical trial of pressure-controlled inverse ratio ventilation and extracorporeal CO2 removal for adult respiratory distress syndrome [ J ]. Am J Respir Crit Care Med, 1994,149 (2Ptl) :295-305.
  • 10Peek GJ, Mugford M, Tiruvoipati R, et al. Efficacy and economic assessment of conventional ventilatory support versus extracorporeal membrane oxygenation for severe adult respiratory failure (CESAR) : a multicentre randomised controlled trial [ J ]. Lancet, 2009,374 (9698) : 1351-1363.

共引文献2363

同被引文献72

引证文献7

二级引证文献13

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部